Nvidia invests $50 million in biotech company Recursion for AI drug discovery

Read Time:7 Second

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

They will pay a combined $9.3 million after the Securities and Exchange Commission charged them for exceeding clients' investment limits...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the...

Workers United represents more than 490 of Starbucks' U.S. cafes and more than 10,000 of its employees.

The changes come a day before Southwest's investor day, when executives will map out the company's plan to cut costs...

Birria has become a popular protein option for tacos, quesadillas, grilled cheese and even ramen.

Visa and MasterCard have surged in the past two decades, reaching a combined $1 trillion market cap. That has attracted...